FDA Modifies Mifepristone REMS Program, Establishes Certification Process for Pharmacies | Polsinelli
On January 3, 2023, FDA released an updated Risk Evaluation and Mitigation Strategy (REMS) for mifepristone. The updated REMS follows a December 2021 FDA announcement that it would...